The scale of the problem
Occupational lung disease remains one of the leading causes of work-related ill health and death in the UK. HSE has made occupational lung disease a priority for inspections in 2025 and 2026, targeting exposures to isocyanates, silica dust, wood dust and other chemical hazards across construction, manufacturing, motor vehicle repair, bakeries and beyond.
In motor vehicle repair, isocyanates accounted for 30 out of 65 new Industrial Injuries Disablement Benefit cases for occupational asthma in 2022 — a figure that has remained stubbornly high despite decades of awareness. Many skilled paint sprayers develop the condition and are forced to leave the industry entirely. Once sensitised, even tiny amounts of exposure can trigger a severe attack and there is no cure. The only management is avoidance.
Silica dust tells a similar story, because the benefit of controlling dust today lands as a prevented diagnosis two decades from now, and the investment keeps getting deferred. It's the most human of biases - we respond to immediate, visible harm far more readily than to slow, invisible accumulation. But the law doesn't make that distinction, and neither does a damaged lung.
What employers get wrong
The most common failure is the gap between having a COSHH assessment on file and actually managing the risk in practice.
HSE's position is that assessing exposure is only the starting point. Controls must be implemented, maintained and regularly reviewed. Health surveillance - monitoring workers for early signs of disease - is a legal requirement wherever a residual risk of harm remains, and yet it is routinely missed.
Health surveillance matters because early detection changes outcomes. A worker identified with early-stage occupational asthma can be moved away from the exposure before the condition becomes disabling. A worker whose symptoms go unnoticed for another three years may never return to their trade.
When did you last genuinely review your controls?
If your business uses chemicals, generates dust, or involves any process where substances are inhaled as a normal part of work, you need to be checking up on your ventilation, monitoring, and health checks.
The harm being done in workplaces today won't show up in a diagnosis until well into the 2030s or beyond. That invisibility is not a protection, it's just a delay.
If you're not sure whether your COSHH arrangements and health surveillance obligations are fit for purpose, we're happy to take a look. It's the kind of thing that's much easier to address before HSE comes to the same conclusion.
👉 Have questions? Talk to us!